Janos Radó comment on the 2017 research article of Lin, Zhang, Feng et al., "Aliskiren increases aquaporin-2 expression and attenuates lithium-induced nephrogenic diabetes insipidus"
Janos Radó’s reply to Samuel Gershon’s comment
Thank you for your remarks. I agree with you completely. There is still a need for adequate clinical validation as to which, if any, is the most effective available therapy and how it should be employed.
I appreciate your interest and useful comments on our work.
December 23, 2021